Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research Grant

This grant opportunity focuses on supporting educational initiatives aimed at primary care providers regarding post-COVID conditions. The goal is to enhance understanding and management of these conditions, particularly in underserved communities. Eligible applicants include healthcare institutions and educational organizations, with an emphasis on innovative programs. The initiative seeks to address health disparities and improve patient outcomes through comprehensive training and resources for healthcare professionals.

Updates in Post-COVID Conditions: Potential Causes, Assessment, Testing, Management, and Ongoing Research
Through this RFP it is our intent to support educational programs on postCOVID conditions targeting primary care providers. These programs should aim to equip primary care providers with the necessary knowledge and skills to identify, diagnose, and manage post-COVID conditions effectively, with a particular interest in programs that address health disparities in the care of marginalized and underserved communities.
Project Types and Area of Interest
Program objectives may include, but are not limited to, the following:
Explain testing and assessment of post-COVID conditions, identify potential causes, and understand its various clinical presentations and potential complicationsOutline the management of post-COVID conditions, including symptom management, referral pathways, pharmacological and nonpharmacological treatments, and ongoing monitoring and follow-up of patientsDescribe strategies to address health disparities such as culturally responsive care, health literacy, community resources, and advocacy for equitable access to care for all patients with post-COVID conditionsSummarize the latest updates in the ongoing research into the potential causes, assessment, testing, and management of post-COVID conditions
All activity types will be considered, with an emphasis on innovative programs that are designed to meet the needs of a large primary care provider audience.

Eligibility

Applicant Eligibility Criteria:Only organizations are eligible to receive grants, not individuals or medical practice groups.
The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.If the project involves multiple departments within an institution and/or between different institutions/organizations/associations. All institutions must have a relevant role and the requesting organization must have a key role in the project.Geographic Scope:United StatesClinical Area:COVID-19Target Audience:Primary Care Providers

Ineligibility

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or diagnostic agents will not be considered.

Application Details

Overview
Through this RFP it is our intent to support educational programs on post-
COVID conditions, also known as Long COVID or PASC. These programs
should aim to equip primary care providers and infectious disease specialists
with the necessary knowledge and skills to identify, diagnose, and manage
post-COVID conditions effectively. Programs addressing health disparities in
the care of marginalized and underserved communities will be of particular
interest.
Project Types and Area of Interest
Program objectives may include, but are not limited to, the following:

• Explain recognition, testing, and assessment of post-COVID conditions,

identify potential causes, and enhance understanding of various clinical
presentations and potential complications.

• Outline the management of post-COVID conditions, including symptom

management, referral pathways, pharmacological and non-pharmacological
treatments, ongoing monitoring and follow-up of patients.

• Describe strategies to address health disparities such as culturally

responsive care, health literacy, community resources, and advocacy for
equitable access to care for all patients with post-COVID conditions.

• Summarize the latest updates in the ongoing research related to the potential

causes, preventative measures, assessment, testing, and management of
post-COVID conditions.
Funding Range and Project Length
Individual projects requesting up to $150,000 will be considered.
Maximum project length is one year.

I. Eligibility
Geographic Scope/Location of Project:

• United States
• Applicant Eligibility Criteria
• • The following may apply: medical, dental, nursing, allied health, and/or pharmacy professional schools;
• healthcare institutions (both large and small); professional organizations/medical societies; medical
• education companies; and other entities with a mission related to healthcare professional education and/or
• healthcare improvement.
• • Only organizations are eligible to receive grants, not individuals or medical practice groups (i.e., an
• independent group of physicians not affiliated with a hospital, academic institution, or professional society).
• • If the project involves multiple departments within an institution and/or between different institutions /
• organizations / associations, all institutions must have a relevant role and the requesting organization must
• have a key role in the project.
• • The applicant must be the project/program lead or an authorized designee of such individual (e.g.,
• project/program lead’s grant coordinator).
• • The project/program lead must be an employee or contractor of the requesting organization.
• Requesting organization must be legally able to receive award funding directly from Pfizer Inc.

recommend that applicants confirm this with their organization or institution prior to submitting an
application. Grants awarded to organizations that are subsequently found to be unable to accept funding
directly from Pfizer Inc. may be subject to rescission.

• For projects offering continuing education credit, the requesting organization must be accredited.

II. Requirements
Primary Area of Interest:

• • VAV - COVID-19 (Antiviral) - KG
• General Area of Interest for this RFP:

Through this RFP it is our intent to support educational programs on post-COVID conditions. These
programs should aim to equip primary care providers and infectious disease specialists with the necessary
knowledge and skills to identify, diagnose, and manage post-COVID conditions effectively, with a particular
interest in programs that address health disparities in the care of marginalized and underserved
communities.
Primary care providers and infectious disease specialists play a critical role in identifying, assessing, and
managing patients with post-COVID conditions. To effectively do so, they must be equipped with a
comprehensive understanding of the clinical presentation and overall impact of post-COVID conditions.
The management of post-COVID conditions is still evolving and primary care providers need to stay up to
date with ongoing research and the latest evidence-based approaches to care to ensure optimal patient
outcomes.
In addition, post-COVID conditions disproportionately affect marginalized and underserved communities.
Providers must be able to recognize and address the social determinants of health that impact outcomes.
Program objectives may include, but are not limited to, the following:

• • Explain testing and assessment of post-COVID conditions, identify potential causes, and
• enhance understanding of its various clinical presentations and potential complications.
• 2
• Outline the management of post-COVID conditions, including symptom management, referral

pathways, pharmacological and non-pharmacological treatments, ongoing monitoring and follow-
up of patients.

• Describe strategies to address health disparities such as culturally responsive care, health

literacy, community resources, and advocacy for equitable access to care for all patients with
post-COVID conditions.

• Summarize the latest updates in the ongoing research related to the potential causes,

assessment, testing, and management of post-COVID conditions.
All activity types will be considered, with an emphasis on innovative programs that are designed to meet
the needs of a large primary care provider audience.
It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeutic or
diagnostic agents will not be considered.
Target Audience:

• • Primary Care Providers, including Family Medicine, Internal Medicine, and Urgent Care Providers
• • Infectious Disease Specialists
• Expected Approximate Monetary Range of Grant Applications:
• Individual projects requesting up to $150,000 will be considered. The estimated total available budget

related to this RFP is $450,000.

• Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy), and

indirect costs.
Key Dates:

• Anticipated Grant Anticipated Project
• RFP Release Date Award Notification End Date
• 30 May 2025
• August 2025 October 2026
• Submission Deadline* Anticipated Project
• 10 July 2025 Start Date
• October 2025
• IMPORTANT: Be advised applications submitted after the due date will not be reviewed.
• *Please note the deadline is 23:59 Eastern Standard Time (e.g., New York, GMT -5)
• How to Submit:
• IMPORTANT: Please read this section carefully since applications submitted not following these instructions
• will not be accepted and will be cancelled.
• • Please go to www.cybergrants.com/pfizer/knowledge and sign in.
• Note: there are individual portals for each grant application type. Please be sure to use the URL

above.
3

• First-time users should click “Create your password”.
• Click the “Start A New Knowledge Gap Application” button.
• Requirements for submission:
• • Complete all required sections of the online application
• • IMPORTANT: Upload proposal (see Appendix) in the General RFP Submission field.
• • In the application:
• • For the question “Competitive Grant?” select “Yes”
• • Select the following Primary Area of Interest: VAV - COVID-19 (Antiviral) - KG
• • Select the following Competitive Grant Program Name: 2025 VAC US Post-COVID Conditions KG
• Questions:
• • If you encounter any technical difficulties with the website, please click here or the “Technical Questions”
• link at the bottom of the page in Cybergrants.
• • Please click here to view “Frequently Asked Questions” regarding the Competitive Grant Program.
• • If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Monika
• Sojewska (Monika.Sojewska@pfizer.com), with the subject line “Post-COVID Conditions: Potential
• Diagnosis, Testing, Management, and Ongoing Research”.
• Review and Approval Process:
• • Grant requests received in response to a general RFP are reviewed by Pfizer to make final grant decisions.
• Mechanism by which Applicants will be Notified:
• • All applicants will be notified via email by the dates noted above.
• • Applicants may be asked for additional clarification during the review period.
• Grant Agreements:
• • If your grant is approved, your institution will be required to enter into a written grant agreement with Pfizer.
• Please click here to view the core terms of the agreement.
• • Under Pfizer's competitive grant program, modifications to grant agreements will not be reviewed unless a

genuine conflict exists as between applicable law and the terms of the relevant grant agreement. Applicant
is encouraged to share the core terms with counsel for approval prior to submitting an application.

• Except where prohibited by applicable law and, in any case, subject to review by Pfizer Legal, payment of

grant funding may only be paid to the grantee organization.

• This RFP is supported by Pfizer Inc. and, if approved the payment will be issued by a Pfizer US based

legal entity.
References:

• • Clinical Overview of Long COVID | COVID-19 | CDC
• • Living with Long COVID | COVID-19 | CDC
• • Long COVID Basics | COVID-19 | CDC
• 4

About Pfizer Grants:

• Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement
• or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s
• medical and/or scientific strategies.
• Pfizer’s competitive grant program involves a publicly posted general Request for Proposal (RFP) that
• provides detail regarding a general area of interest, sets timelines for review and approval, and uses an

internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application
addressing the research gaps as outlined in the specific RFP.
For all Investigator Sponsored Research (ISRs) and general research grants, the grant requester (and
ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the
independent initiative supported by the grant, including compliance with any regulatory requirements. Pfizer
must not be involved in any aspect of study protocol or project development, nor the conduct or monitoring of
the research program. An ISR grant request cannot be submitted for a study that has already commenced
and was not originally supported by Pfizer.

IMPORTANT: RFP Submission Requirements
Applications will be accepted via the online portal listed in the How to Submit section. Project Proposals should
be single-spaced using Calibri 12-point font and 1-inch margins. Note there is a 15-page limit exclusive of
references. When uploading your Project Proposal please ensure it addresses the following sections:

• Goals and Objectives
• • Briefly state the overall goal of the project.
• • List the objectives you plan to meet with your project, in terms of learning and expected outcomes.
• Assessment of Need for the Project
• • Include a description of your organization’s needs assessment for this proposed project which may include
• a quantitative baseline data summary, initial metrics, or a project starting point (please cite data on gap
• analyses or relevant patient-level data that informs the stated objectives) in your target area.
• Target Audience
• Describe the primary audience(s) targeted for this project. Indicate whom you believe will directly benefit

from the project outcomes. Describe the overall population size as well as the size of your sample
population.
Project Design and Methods

• Describe the planned project, the educational approach, and the way the planned methods address the

established need.
Innovation

• Explain what measures you have taken to assure that this project is original and does not duplicate other

projects or materials already developed. Describe how this project builds upon existing work, pilot projects,
or ongoing projects developed either by your institution or other institutions.
Evaluation and Outcomes

• In terms of the metrics used for the needs assessment, describe how your organization will determine if

the gap was addressed for the target group. Identify the sources of data your organization anticipates using
to make the determination. Describe how your organization is expected to collect and analyze the data.

• Explain the method used to control for other factors outside this project (e.g., use of a control group or

comparison with baseline data). Quantify the amount of change expected from this project in terms the
target audience. Describe how your organization will determine if the target audience was fully engaged in
the project.
Dissemination Plan

• Describe how the project may have extended benefit beyond the grant. Will the teaching materials be

made available to others to use? Will there be tools or resources that are made publicly available beyond
the initial project. Describe how the project outcomes might be broadly disseminated.
Anticipated Project Timeline

• Provide an anticipated timeline for your project including project start/end dates.

Additional Information

• Provide an anticipated timeline for your project including project start/end dates.

Organization Detail

• Describe the attributes of the institutions / organizations / associations that will support and facilitate the

execution of the project and the leadership of the proposed project. Articulate the specific role of each
partner in the proposed project.
Budget Detail

• Please include a budget narrative that describes in greater detail the line items specified in the budget

submitted within the application.

• While estimating your budget please keep the following items in mind:
• 6
• Independent Medical Education Grants awarded by GMGP cannot be used to purchase therapeutic assets

(prescription or non-prescription).

• Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer. Please click

here for details. General organizational running costs such as legal fees, insurance, heating and lighting
etc. should be included in an Institutional Overhead (if required). These costs are not specific to a grant
request and therefore, should not appear as line items in budgets. However, costs that are specific to the
study (e.g., some countries require insurance to be taken out on a per-study basis for clinical research)
would be acceptable to be included as line items.